Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis.
Anne-Catherine POULEUR – chef de clinique service de cardiologie – institut cardiovasculaire Saint Luc – BRUXELLES BELGIQUE Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. – https://pubmed.ncbi.nlm.nih.gov/32653448/ PMID : 32653448
Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic
François ROUBILLE – cardiologue resp. équipe médicale insuffisance cardiaque – CHU Montpellier Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic https://pubmed.ncbi.nlm.nih.gov/33352187/ PMID : 33352187
Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis.
Frédéric MOUQUET – cardiologue LIlle Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis. https://pubmed.ncbi.nlm.nih.gov/34497140/ PMID : 34497140
Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis.
Lise LEGRAND – Cardiologue APHP Pitié Salpêtrière PARIS Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis. JACC CardioOncol2020;2:414–42 – https://pubmed.ncbi.nlm.nih.gov/33073249/ PMID : 33073249
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
Patricia REANT Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis. https://pubmed.ncbi.nlm.nih.gov/34472567/ PMID : 34472567
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis.
Damien GUIJARRO Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis. https://pubmed.ncbi.nlm.nih.gov/34419399/ PMID : 34419399
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities.
Olivier LAIREZ : Cardiologue CHU Rangueil – Toulouse Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities. https://pubmed.ncbi.nlm.nih.gov/33840100/ PMID : 33840100
Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms
Marc-Antoine DELBARRE – interniste CHU Henri MONODR Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms. Shinichi Goto et al. Nat Commun. 2021. PMID : 33976142
Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.
Olivier HUTTIN Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis. https://pubmed.ncbi.nlm.nih.gov/33980765/ PMID : 33980765
Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
Silvia OGHINA Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation. https://pubmed.ncbi.nlm.nih.gov/33980765/ PMID : 32387068
